155057-97-9 Usage
General Description
8-Bromo-1,6-naphthyridin-5(6H)-one is a chemical compound with the molecular formula C9H5BrN2O. It is a brominated derivative of 1,6-naphthyridinone and belongs to the class of heterocyclic compounds. 8-Bromo-1,6-naphthyridin-5(6H)-one is commonly used in the synthesis of pharmaceuticals and agrochemicals due to its diverse biological activities, including antimicrobial, antifungal, and anticancer properties. It has also been studied for its potential applications in materials science, such as in the development of organic semiconductors and fluorescent probes. 8-Bromo-1,6-naphthyridin-5(6H)-one is commercially available and can be obtained from various chemical suppliers for research purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 155057-97-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,0,5 and 7 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 155057-97:
(8*1)+(7*5)+(6*5)+(5*0)+(4*5)+(3*7)+(2*9)+(1*7)=139
139 % 10 = 9
So 155057-97-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrN2O/c9-6-4-11-8(12)5-2-1-3-10-7(5)6/h1-4H,(H,11,12)
155057-97-9Relevant articles and documents
ANTI-FIBROTIC PYRIDINONES
-
, (2015/11/02)
This application relates to polycyclic compounds with a pyridinone or pyridinone derivative core including, substituted pyridinones, 5,6- and 6,6- bicyclic heterocycles and substituted pyridine-thiones. This application also discloses methods of preparing these polycyclic compounds, pharmaceutical compositions and medicaments comprising said compounds and methods to treat, prevent or diagnose diseases, disorders or conditions associated with fibrosis.
Ready access to 7,8-dihydro- and 1,2,3,4-tetrahydro-1,6-naphthyridine-5(6H) -ones from simple pyridine precursors
Showalter, H. D. Hollis
, p. 1311 - 1317 (2007/10/03)
Short pathways are described for the synthesis of a representative example of each of the 7,8-dihydro- and 1,2,3,4-tetrahydro-1,6-naphthyridine-5(6H)-one ring systems from simple pyridine precursors. An attempted synthesis of the related 4,6-dihydro-1,6-naphthyridin-5(1H)-one ring system from a common intermediate was unsuccessful.
